Details of the Drug

General Information of Drug (ID: DMMNGO3)

• Drug Name: RS-118641
• Synonyms: A-500359A; A-500359E; Capuramycin derivative translocase inhibitors (tuberculosis); SQ-641; Capuramycin derivative translocase inhibitors (tuberculosis), Sequella; SQ-641-aua; SQ-922-aua; Translocase inhibitors (tuberculosis), Sankyo

Indication

Disease Entry	ICD 11	Status	REF
Bacterial infection	1A00-1C4Z	Investigative	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C34H51N5O13
  Canonical SMILES: CCCCCCCCCC(=O)OC1C(C(OC1N2C=CC(=O)NC2=O)C(C(=O)N)OC3C(C(C=C(O3)C(=O)NC4CCCC(NC4=O)C)O)O)OC
  InChI: InChI=1S/C34H51N5O13/c1-4-5-6-7-8-9-10-14-23(42)50-28-25(48-3)26(51-32(28)39-16-15-22(41)38-34(39)47)27(29(35)44)52-33-24(43)20(40)17-21(49-33)31(46)37-19-13-11-12-18(2)36-30(19)45/h15-20,24-28,32-33,40,43H,4-14H2,1-3H3,(H2,35,44)(H,36,45)(H,37,46)(H,38,41,47)/t18-,19+,20+,24+,25-,26+,27-,28-,32-,33-/m1/s1
  InChIKey: MTVCVDHANKHRCR-MNJNIPBHSA-N
• Cross-matching ID:
  PubChem CID: 3013049
  CAS Number: 254449-23-5
  TTD ID: D0Y0KV
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug

References

• [1] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.